Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

China flag China · Delayed Price · Currency is CNY
36.44
-0.37 (-1.01%)
Jun 18, 2026, 3:04 PM CST
Market Cap13.15B -5.7%
Revenue (ttm)2.62B +23.0%
Net Income756.37M +68.4%
EPS2.12 +68.7%
Shares Out 357.32M
PE Ratio17.32
Forward PEn/a
Dividend1.17 (3.17%)
Ex-Dividend DateMay 22, 2026
Volume5,427,187
Open36.36
Previous Close36.81
Day's Range36.21 - 37.20
52-Week Range34.37 - 59.07
Beta0.25
AnalystsStrong Buy
Price Targetn/a
Earnings DateAug 28, 2026

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicin... [Read more]

Sector Healthcare
Founded 1977
Employees 2,396
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300573
Full Company Profile

Financial Performance

In 2025, SHE:300573's revenue was 2.47 billion, an increase of 27.24% compared to the previous year's 1.94 billion. Earnings were 695.86 million, an increase of 105.84%.

Financial Statements